Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota

FEMS Immunology and Medical Microbiology

Volumn 63, Issue 3, 2011, Pages 346-354

  Steed, Helen ^a   Macfarlane, George T ^a   Blackett, Katie L ^a   Macfarlane, Sandra ^a   Miller, Michael H ^a   Bahrami, Bahram ^a   Dillon, John F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bacterial overgrowth; Chronic liver disease; Cirrhosis; Small bowel

Indexed keywords

DNA; INTERLEUKIN 18; INTERLEUKIN 8; PROTON PUMP INHIBITOR; RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; BACTEROIDES; BIFIDOBACTERIUM; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA EXTRACTION; DUODENUM BIOPSY; ENTEROBACTERIACEAE; ENTEROCOCCUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE FLORA; LACTOBACILLUS; LIVER CIRRHOSIS; MALE; MORAXELLA; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SMALL INTESTINE; STAPHYLOCOCCUS; STREPTOCOCCUS;

ADOLESCENT; ADULT; AGED; BACTERIA; BACTERIAL TRANSLOCATION; BIOTA; BLOOD; CYTOKINES; DNA, BACTERIAL; DUODENUM; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, BACTERIAL; SEPSIS; YOUNG ADULT;

EID: 80755167706     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00857.x     Document Type: Article

References (50)

1. Altman KW, Chhaya V, Hammer ND, Pavlova S, Vesper BJ, Tao L & Radosevich JA (2008) Effect of proton pump inhibitor pantoprazole on growth and morphology of oral Lactobacillus strains. Laryngoscope 118: 599-604.
2. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R & Stahl DA (1990) Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 56: 1919-1925.
3. Bartosch S, Fite A, Macfarlane GT & McMurdo MET (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Env Microbiol 70: 3575-3581.
4. Bernhard AE & Field KG (2000) Identification of nonpoint sources of fecal pollution in coastal waters by using host-specific 16S ribosomal DNA genetic markers from fecal anaerobes. Appl Environ Microbiol 66: 1587-1594.
5. Betzl D, Ludwig W & Schleifer KH (1990) Identification of lactococci and enterococci by colony hybridization with 23S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 56: 2927-2929.
6. Bode JC, Bode C, Heidelbach R, Dürr H-K & Martini GA (1984) Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 31: 30-34.
7. Boeuf P, Vigan-Womas I, Jublot D, Loizon S, Barale JC, Akanmori BD, Mercereau-Puijalon O & Behr C (2005) Cyproquant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunology 6: 5.
8. Campbell MS, Obstein K, Reddy KR & Yang YX (2008) Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci 53: 394-398.
9. Crowther JS (1971) Transport and storage of faeces for bacteriological examination. J Appl Bacteriol 34: 477-483.
10. Feld JJ, Meddings J & Heathcote EJ (2006) Abnormal intestinal permeability in primary billiary cirrhosis. Dig Dis Sci 51: 1607-1613.
11. Furrie E, Macfarlane S, Kennedy A, Cummings JH & Macfarlane GT (2005a) Synbiotic therapy (Bifidobacterium longum/Synergy I) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled trial. Gut 54: 242-249.
12. Furrie E, Macfarlane S, Thomson G & Macfarlane GT (2005b) Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115: 565-574.
13. Garault P, Letort C, Juillard V & Monnet V (2000) Branched chain amino acid biosynthesis is essential for optimal growth of Streptococcus thermophilus in milk. App Environ Microbiol 66: 5128-5133.
14. Garcia-Tsao G (1992) Spontaneous bacterial peritonitis. Gastroenterol Clin N Am 21: 257-275.
15. Genescà J, Martí R, Rojo F et al. (2003) Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 52: 1054-1059.
16. Heilig HG, Zoetendal EG, Vaughan EE, Marteau P, Akkermans AD & de Vos WM (2002) Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 68: 114-123.
17. Huijsdens XW, Linskens RK, Mak M, Meuwissen SG, Vandenbroucke-Grauls CM & Savelkoul PH (2002) Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 40: 4423-4427.
18. James JH, Hodgman JM & Funovvics JM (1976) Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids. Metabolism 25: 471-476.
19. Kalaitzakis E, Johansson JE, Bjarnason I & Björnsson E (2006) Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol 41: 326-330.
20. Kempf VA, Trebesius K & Autenrieth IB (2000) Fluorescent in situ hybridization allows rapid identification of microorganism in blood cultures. J Clin Microbiol 38: 830-838.
21. Koh IH, Guatelli R, Montero EF, Keller R, Silva MH, Goldenberg S & Silva RM (1996) Where is the site of bacterial translocation - small or large bowel? Transplant Proc 28: 2667-2668.
22. Kok RG, de Waal A, Schut F, Welling GW, Weenk G & Hellingwerf KJ (1996) Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl Env Microbiol 62: 3668-3672.
23. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH & Welling GW (1995) Quantitative fluorescent in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61: 3069-3075.
24. Lewis SJ, Franco S, Young G & O'Keefe SJD (1996) Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. APT 10: 557-561.
25. Li L, Wu Z, Ma W, Yu Y & Chen Y (2001) Changes in intestinal microflora in patient with chronic severe hepatitis. Chin Med J 114: 869-872.
26. Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK, Hedl M, Nicolae DL, Abraham C & Cho JH (2004) Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations. Human Mol Gen 13: 1715-1725.
27. Loguercio C, Abbiati R, Rinaldi M, Romano A, Del Vecchio Blanco C & Coltorti M (1995) Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. J Hepatol 23: 39-46.
28. Macfarlane GT, Gibson GR, Beatty E & Cummings JH (1992) Estimation of short chain fatty acid production from protein by human intestinal bacteria, based on branched chain fatty acid measurements. FEMS Microbiol Ecol 101: 81-88.
29. Macfarlane S, Furrie E, Cummings JH & Macfarlane GT (2004) Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38: 1690-1699.
30. Manz W, Amann R, Ludwig W, Vancanneyt M & Schleifer KH (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophyga-flavobacter-bacteroides in the natural environment. Microbiology 142: 1097-1106.
31. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi FF, Abbiati R & Italian BCAA Study Group (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double blind randomized trial. Gastroenterology 124: 1792-1801.
32. Meier H, Koob C, Ludwig W, Amann R, Frahm E, Hoffmann S, Obst U & Schleifer KH (1997) Detection of enterococci with rRNA targeted DNA probes and their use for hygienic drinking water control. Water Sci Technol 35: 437-444.
33. Mills OE & Thomas TD (1921) Nitrogen sources for growth of lactic streptococci in milk. NZJ Dairy Sci Technol 15: 43-55.
34. Nadkarni MA, Martin E, Jacques NA & Hunter N (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257-266.
35. O'May GA, Reynolds N & Macfarlane GT (2005) Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients. Appl Environ Microbiol 71: 4777-4783.
36. Pérez-Paramo M, Muñoz J, Albillos A, Freile I, Portero F, Santos M & Ortiz-Berrocal J (2000) Effect of propanolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 31: 43-48.
37. Poxton IR, Brown R, Sawyer A & Ferguson A (1997) Mucosa-associated bacterial flora of the human colon. J Med Microbiol 46: 85-91.
38. Read AE, McCarthy CF, Heaton KW & Laidlaw J (1966) Lactobacillus acidophilus in treatment of hepatic encephalopathy. BMJ 5498: 1267-1269.
39. Rintilla T, Kassinen A, Malinen E, Krougius L & Palva A (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97: 1166-1177.
40. Schafer DF, Fowler JM & Jones EA (1981) Colonic bacteria: a source of gamma-aminobutyric acid in blood. Proc Soc Exp Biol Med 167: 301-303.
41. Schalm SW & Van Der May T (1979) Hyperammonemic coma after hepatectomy in germ-free rats. Gastroenterology 77: 231-234.
42. Sghir A, Antonopoulos D & Mackir RI (1998) Design and evaluation of a Lactobacillus group-specific ribosomal RNA-targeted hybridization probe and its application to the study of intestinal microecology in pigs. Syst Appl Microbiol 21: 291-296.
43. Smith EA & Macfarlane GT (1997) Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe 3: 327-337.
44. Smith EA & Macfarlane GT (1998) Enumeration of amino acid fermenting bacteria in the human large intestine: effects of pH and carbohydrate availability on peptide and dissimilatory amino acid metabolism. FEMS Microbiol Ecol 25: 355-368.
45. Steinke DT, Weston TL, Morris AD, MacDonald TM & Dillon JF (2002) The epidemiology of liver disease in Tayside database: a population-based record-linkage study. J Biomed Inform 35: 186-193.
46. Thulstrap AM, Sorensen HT, Schonheyder HC, Moller JK & Tage-Jensen U (2000) Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 31: 1357-1361.
47. Walter J, Hertel C, Tannock GW, Lis CM, Munro K & Hammes WP (2001) Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67: 2578-2585.
48. Weber FL Jr, Banwell JG, Fresard KM & Cummings JH (1987) Nitrogen in fecal bacteria, fiber, and soluble fractions in patients with cirrhosis: effects of lactulose and lactulose plus neomycin. J Lab Clin Med 10: 259-263.
49. Yoshida H, Hamada T, Inuzuka S, Ueno T, Sata M & Tanikawa K (1993) Bacterial infections in cirrhosis with and without hepatocellular carcinoma. Am J Gastroenterol 88: 2067-2071.
50. Yuraydin C, Walsh TJ, Engler HD, Ha JH, Li Y, Jones EA & Basile AS (1995) Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy. Brain Res 679: 42-48.